psychiatry neurology
Abnormal Involuntary Movement Scale (AIMS)
Clinician-rated 12-item scale for assessing tardive dyskinesia and other abnormal involuntary movements in patients on antipsychotic medications. Items 1–7 are scored 0–4; items 8–12 are additional assessments.
References
- Guy W. ECDEU Assessment Manual for Psychopharmacology (Revised). National Institute of Mental Health. 1976.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Risperidone (Paediatric) · Atypical Antipsychotic — Autism Spectrum Disorder / Schizophrenia / Tic Disorders
- Tetrabenazine · VMAT2 Inhibitor — Hyperkinetic Movement Disorders
- Droperidol · Butyrophenone antipsychotic / antiemetic
- Quetiapine (Elderly — Dementia Caution) · Atypical Antipsychotic
- Haloperidol (Delirium) · Typical Antipsychotic (Butyrophenone)
- Olanzapine · Second-Generation Antipsychotic
Pathways
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF
- Alcohol Withdrawal Management · NICE CG115 2010 / BNF
- Eating Disorder Assessment · NICE CG9 2017 / MARSIPAN
- Serotonin syndrome · Hunter criteria (Dunkley 2003); TOXBASE/NPIS; BNF
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.